Treosulfan
Showing 1 - 25 of 48
Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)
Not yet recruiting
- Multiple Myeloma
- Melphalan and Treosulfan
- Melphalan
- (no location specified)
Dec 5, 2022
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial
Not yet recruiting
- Acute Myeloid Leukaemia (AML)
- +2 more
- Treosulfan
- Fludarabine
- (no location specified)
Sep 6, 2022
MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Venetoclax
- +4 more
-
Aachen, NRW, Germany
- +2 more
Mar 29, 2023
Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)
Completed
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +3 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,
Completed
- Acute Biphenotypic Leukemia
- +6 more
- Cyclosporine
- +6 more
-
Aurora, Colorado
- +2 more
Jan 12, 2022
Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies Trial in Worldwide (Treosulfan, Busilvex)
Active, not recruiting
- Primary Immunodeficiencies
- +3 more
- Treosulfan
- Busilvex
-
Prague, Czechia
- +20 more
Apr 19, 2022
Patients Receiving Mismatched Allogeneic HCT Trial in Germany (immunosuppression)
Terminated
- Patients Receiving Mismatched Allogeneic HCT
-
Mainz, Germany
- +3 more
Jun 29, 2022
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (procedure, biological, drug, other, radiation)
Completed
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Allogeneic Bone Marrow Transplantation
- +11 more
-
Aurora, Colorado
- +5 more
Jul 21, 2021
Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,
Active, not recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
- Allogeneic Bone Marrow Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 13, 2021
Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute Trial in Milano (Conditioning treatment
Terminated
- Irradiated Bone Marrow
- +4 more
- Conditioning treatment "Treosulfan-TMI"
- +2 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Oct 13, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +23 more
- treosulfan
- +7 more
-
Denver, Colorado
- +2 more
Jun 17, 2021
Nijmegen Breakage Syndrome Trial in Moscow (Treosulfan)
Recruiting
- Nijmegen Breakage Syndrome
- Treosulfan
-
Moscow, Russian FederationHSCT department
Jun 23, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Worldwide (Busulfan, Treosulfan)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Busulfan
- Treosulfan
-
Helsinki, Finland
- +32 more
Jul 29, 2020
Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), MDS (MDS) Trial in Worldwide (Treosulfan)
Completed
- Acute Lymphoblastic Leukaemias (ALL)
- +3 more
- Treosulfan
-
Vienna, Austria
- +23 more
Apr 30, 2020
Children Undergoing Allogeneic HSCT
Completed
- Allogeneic Haematopoietic Stem Cell Transplantation
- Treosulfan
-
London, United Kingdom
- +1 more
Sep 3, 2019
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Ewing's Sarcoma Trial in Essen, Muenster (Zoledronic acid, Busulfan, Treosulfan)
Completed
- Ewing's Sarcoma
- Zoledronic acid
- +2 more
-
Essen, Germany
- +1 more
Oct 18, 2019
Uveal Melanoma Trial in Spain (ipilimumab, Nivolumab)
Completed
- Uveal Melanoma
-
Palma De Mallorca, Baleares, Spain
- +9 more
Mar 8, 2022
Myelofibrosis Trial (Allogenic transplantation transplantation)
Not yet recruiting
- Myelofibrosis
- Allogenic transplantation transplantation
- (no location specified)
Jan 24, 2021
Refractory Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Moscow (Preparative regimen)
Recruiting
- Refractory Acute Myeloid Leukemia
- Refractory Acute Lymphoblastic Leukemia
- Preparative regimen
-
Moscow, Russian FederationDmitry Rogachev National Research Center of Pediatric Hematology
Nov 19, 2020
GVHD, Hematologic Malignancy, Cyclophosphamide Adverse Reaction Trial (Post-transplantation Cyclophosphamide at dose 25
Not yet recruiting
- Graft Versus Host Disease
- +2 more
- Post-transplantation Cyclophosphamide at dose 25 mg/kg/day
- Post-transplantation Cyclophosphamide at dose 50 mg/kg/day
- (no location specified)
Dec 17, 2021
Acute Lymphoblastic Leukaemia Trial in Worldwide (VP16, TBI, Thiotepa)
Recruiting
- Acute Lymphoblastic Leukaemia
- VP16
- +8 more
-
Buenos Aires, Argentina
- +118 more
Sep 29, 2020